Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by MSD .
Filed returns
38
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | MSD | Health | Oncology nursing workforce and cancer care service policy (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2026 | MSD | Health | Pulmonary Arterial Hypertension (PAH) services (Public policy or programme) | 8 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | National Cancer Strategy & future of cancer care in Ireland (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | EU Safe Hearts Plan (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Cancer Outcomes in Ireland (Public policy or programme) | 10 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | Health and industry policy (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | Advocacy on Pulmonary Arterial Hypertension Policy in Ireland (Public policy or programme) | 10 | On lobbying.ie |
| Sep–Dec 2024 | MSD | Health | Health Policy Development for New Programme for Government (Public policy or programme) | 46 | On lobbying.ie |
| May–Aug 2024 | MSD | Health | European policy on innovative pharmaceutical medicine (Public policy or programme) | 19 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | Access to Innovative Medicines (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | To highlight problems in Ireland faced by patients with TNBC and policy areas that need focus. (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | Access to innovative cancer medicines (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | Early detection and treatment of cancer (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2023 | MSD | Health | Early detection and treatment of cancer (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2022 | MSD | Economic Development and Industry | Positioning Ireland in the Global Biopharmaceutical Industry (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2022 | MSD | Health | Immunisation Policies (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2022 | MSD | Health | Immunisation Policies (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2021 | MSD | Health | Immunisation Policies (Public policy or programme) | 26 | On lobbying.ie |
| Sep–Dec 2021 | MSD | Health | Cancer Care in a post-pandemic COVID-19 era (Public policy or programme) | 15 | On lobbying.ie |
| May–Aug 2021 | MSD | Health | Cancer Care in a post-pandemic COVID-19 era (Public policy or programme) | 18 | On lobbying.ie |
| Jan–Apr 2021 | MSD | Health | Oncology Policy (Public policy or programme) | 9 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Policy Priorities in a post-pandemic COVID-19 era (Public policy or programme) | 26 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Oncology Policy (Public policy or programme) | 34 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Immunisation Policies (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2019 | MSD | Health | Immunisation Policies (Public policy or programme) | 46 | On lobbying.ie |
| May–Aug 2019 | MSD | Health | Accessing Innovative Medicines (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2019 | MSD | Economic Development and Industry | Development of the Pharmaceutical industry in Ireland (Public policy or programme) | 42 | On lobbying.ie |
| Jan–Apr 2019 | MSD | Health | Immunisation Policies (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2019 | MSD | Health | Accessing Innovative Medicines (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2019 | MSD | Economic Development and Industry | Development of the Pharmaceutical industry in Ireland (Public policy or programme) | 91 | On lobbying.ie |
| Sep–Dec 2018 | MSD | Health | Lung Cancer Policy (Public policy or programme) | 54 | On lobbying.ie |
| Sep–Dec 2018 | MSD | Health | Access to Innovative Medicines (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2018 | MSD | Economic Development and Industry | Biopharma Investment and Development (Public policy or programme) | 29 | On lobbying.ie |
| Sep–Dec 2017 | MSD | Health | Access to innovation in Oncology (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2017 | MSD | Health | Oncology Policy (Public policy or programme) | 19 | On lobbying.ie |
| May–Aug 2017 | MSD | Health | Immunisation Programmes (Public policy or programme) | 19 | On lobbying.ie |
| Sep–Dec 2016 | MSD | Health | Immunisation Programmes (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2016 | MSD | Health | Future Healthcare Policy (Public policy or programme) | 25 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 34 | 89.5% | |
| Economic Development and Industry | 4 | 10.5% |